Search hospitals
>
North Carolina
>
Durham
Durham VA Medical Center, Durham, NC
Claim this profile
Durham, North Carolina 27705
Global Leader in Lung Cancer
Global Leader in Post-Traumatic Stress Disorder
Conducts research for Prostate Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
335 reported clinical trials
42 medical researchers
Summary
Durham VA Medical Center, Durham, NC is a medical facility located in Durham, North Carolina. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Prostate Cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Durham VA Medical Center, Durham, NC is involved with conducting 335 clinical trials across 407 conditions. There are 42 research doctors associated with this hospital, such as Michael J. Kelley, Gerald Grant, MD, Rhonda Bitting, MD, and Daphne R. Friedman.
Area of expertise
Lung Cancer
Durham VA Medical Center, Durham, NC has run 43 trials for Lung Cancer. Some of their research focus areas include:
Post-Traumatic Stress Disorder
Durham VA Medical Center, Durham, NC has run 37 trials for Post-Traumatic Stress Disorder.
Top PIs
Michael J. Kelley
Durham VA Medical Center
6 years of reported clinical research
Gerald Grant, MD
Stanford University Medical Center
4 years of reported clinical research
Rhonda Bitting, MD
Durham VA Medical Center, Durham, NC
4 years of reported clinical research
Daphne R. Friedman
Durham VA Medical Center
6 years of reported clinical research
Clinical Trials running at Durham VA Medical Center, Durham, NC
Lung Cancer
Prostate Cancer
Cancer
Post-Traumatic Stress Disorder
Non-Small Cell Lung Cancer
Lymphoma
Bladder Cancer
Chronic Lymphocytic Leukemia
Pancreatic Cancer
Multiple Myeloma
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Cemiplimab
for Non-Small Cell Lung Cancer
This phase II/III Expanded Lung-MAP treatment trial compares the effect of adding cemiplimab to docetaxel and ramucirumab versus docetaxel and ramucirumab alone in treating patients with non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Cemiplimab is a monoclonal antibody that stimulates the immune system by blocking the PD-1 pathway. Tumors use the PD-1 pathway to escape attacks from the immune system. By blocking the PD-1 pathway, cemiplimab may help the immune system recognize and attack tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Adding cemiplimab to usual treatment, docetaxel and ramucirumab, may kill more tumor cells compared to docetaxel and ramucirumab alone in treating patients with stage IV or recurrent non-small cell lung cancer.
Recruiting
1 award
Phase 2 & 3
19 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Durham VA Medical Center, Durham, NC?
Durham VA Medical Center, Durham, NC is a medical facility located in Durham, North Carolina. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Prostate Cancer, Cancer, Non-Small Cell Lung Cancer and other specialties. Durham VA Medical Center, Durham, NC is involved with conducting 335 clinical trials across 407 conditions. There are 42 research doctors associated with this hospital, such as Michael J. Kelley, Gerald Grant, MD, Rhonda Bitting, MD, and Daphne R. Friedman.
Where is Durham VA Medical Center, Durham, NC located?
Directions to Durham VA Medical Center: From I-85, take exit 172 for Durham Freeway South (Route 147). Follow signs for Duke and VA Medical Centers to exit 15 (Fulton Street). Turn right at the bottom of the exit ramp and continue approximately 1/4 mile; the Durham VA Medical Center will be on your right.
Who should I call to ask about financial aid or insurance network?
**Durham VA Medical Center - Financial Assistance and Insurance Departments** - **Main Phone Number:** 919-286-0411 - **Copay Balance Inquiries:** For questions regarding your VA health care bill's copay balance, please call the toll-free number provided. - **In-Person Payments:** Visit the Agent Cashier Window in Room F1194, 1st floor. Open Monday through Friday, 8:00 a.m. to 4:30 p.m.
What insurance does Durham VA Medical Center, Durham, NC accept?
The Durham VA Medical Center in Durham, North Carolina, accepts a wide range of insurance plans. These include commercial health insurance plans such as Aetna, Blue Cross Blue Shield of North Carolina, CIGNA Healthcare of NC, Humana, Optima Health, Progyny, and United Healthcare. Additionally, exchange health insurance through Healthcare.gov (Cigna Healthcare of NC), governmental health insurance plans like Medicare Advantage Plans, Medicaid Managed Care (NC plans only), and National Transplant Networks (Aetna Institutes of Excellence, Blue Distinction Centers for Transplant, CIGNA LifeSource Transplant Network, and Humana National Transplant Network) are accepted.
What awards or recognition has Durham VA Medical Center, Durham, NC received?
The Durham VA Medical Center, located in Durham, North Carolina, is renowned for its contributions to health services research, evidenced by the Research Career Scientist Award (RCS). It is integral to the Cooperative Studies Program Epidemiology Center (CSPEC)-Durham, a key player among six national epidemiology centers dedicated to population-based research. Additionally, the center is supported by the Institute for Medical Research, which focuses on enhancing the health and lives of veterans, their families, and the public through research and education.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.